As expect, roughly the same revenue as May, despite close to double the generation. The loss of LGC sales really hurt the bottom line.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025